The Disparities in Myasthenia Gravis Clinical Trial Enrollment in the United States and Canada
The geographic distribution of enrollment suggests a possible concern that many patients do not have convenient access to trial centers. Strategies are needed to facilitate greater clinical trial participation among underrepresented and underserved communities that will improve generalization of study results to the overall MG population.
Authors
- Danelvis Paredes (ORCID: https://orcid.org/0000-0002-3525-7696)
- James F. Howard (ORCID: https://orcid.org/0000-0002-7136-8617)
- Stephen L. Aita (ORCID: https://orcid.org/0000-0001-7201-3247)
- Jose Alfredo Sanchez (ORCID: https://orcid.org/0000-0003-4847-5817)
- Jeffrey T. Guptill
Institutions
- University of North Carolina at Chapel Hill (US)
- Addgene (US)
- Duke Medical Center (US)
- University of South Alabama (US)
Publication Details
- Journal
- Muscle & Nerve
- Published
- 2025-12-24
- DOI
- https://doi.org/10.1002/mus.70125
- Primary Topic
- Myasthenia Gravis and Thymoma
- Type
- article
- Field-Weighted Citation Impact
- 0.00